Genomic Associations of Chemoimmunotherapy Outcomes in a Real-World Cohort of Small Cell Lung Cancer (SCLC) Patients

被引：0
|
作者：
Ullah, A. T. [1 ]
Quintanilha, J. [2 ]
Graf, R. [2 ]
Oxnard, G. [2 ]
Riess, J. W. [1 ]
机构：
[1] UC Davis Comprehens Canc Ctr, Sacramento, CA USA
[2] Fdn Med Inc, Cambridge, MA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Small Cell Lung Cancer; Immune Checkpoint Inhibitors; Genomic Associations;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.13-03
引用
收藏
页码：S367 / S368
页数：2
相关论文
共 50 条
  • [1] Treatment patterns and clinical outcomes of extensive stage small cell lung cancer (SCLC) in the real-world evidence ESME cohort before the era of immunotherapy
    Valette, Clarisse Audigier
    Filleron, Thomas
    Debieuvre, Didier
    Lena, Herve
    Perol, Maurice
    Chouaid, Christos
    Simon, Gaetane
    Quantin, Xavier
    Girard, Nicolas
    RESPIRATORY MEDICINE AND RESEARCH, 2023, 84
  • [2] Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer
    Cramer-van der Welle, Christine M.
    Schramel, Franz M. N. H.
    van Leeuwen, Arvid S.
    Groen, Harry J. M.
    van de Garde, Ewoudt M. W.
    EUROPEAN JOURNAL OF CANCER CARE, 2020, 29 (05)
  • [3] A systematic literature review of real-world treatment outcomes of small cell lung cancer
    Stokes, Michael
    Berfeld, Noami
    Gayle, Alicia
    Descoteaux, Andrew
    Rohrmoser, Oscar
    Franks, April
    MEDICINE, 2022, 101 (26) : E29783
  • [4] Real-World Outcomes in Patients with 3rd-Line Extensive Stage Small Cell Lung Cancer
    Bar, J.
    Xu, Q.
    Karve, S.
    Jeng, E. E.
    Alexandroff, S.
    Ready, N. E.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S704 - S704
  • [5] Developing a Real-World 3L Comparator to CheckMate 032: Overall Survival (OS) in Patients with Small Cell Lung Cancer (SCLC)
    Schwartzberg, L.
    Korytowsky, B.
    Penrod, J.
    Yuan, Y.
    Gu, T.
    Le, T.
    Abraham, P.
    Selvaggi, G.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S581 - S582
  • [6] Real-world treatment patterns and outcomes of patients with small cell lung cancer progressing after 2 lines of therapy
    Coutinho, Anna D.
    Shah, Manan
    Lunacsek, Orsolya E.
    Eaddy, Michael
    Willey, Joanne P.
    LUNG CANCER, 2019, 127 : 53 - 58
  • [7] Real-World Analysis of Clinical Characteristics and Survival Outcomes in Patients With Extensive-Stage SCLC Treated With First-Line Chemoimmunotherapy
    Wang, Yang
    Mathai, Jared
    Alamgeer, Muhammad
    Parakh, Sagun
    Paul, Eldho
    Mitchell, Paul
    Arulananda, Surein
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (08):
  • [8] Efficacy outcomes and prognostic factors from real-world patients with advanced non-small-cell lung cancer treated with first-line chemoimmunotherapy: The Spinnaker retrospective study
    Banna, Giuseppe L.
    Cantale, Ornella
    Muthuramalingam, Sethupathi
    Cave, Judith
    Comins, Charles
    Cortellini, Alessio
    Addeo, Alfredo
    Signori, Alessio
    McKenzie, Hayley
    Escriu, Carles
    Barone, Gloria
    Chan, Samuel
    Hicks, Alexander
    Bainbridge, Hannah
    Pinato, David J.
    Ottensmeier, Christian
    Gomes, Fabio
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 110
  • [9] Modulation of chemoimmunotherapy efficacy in non-small cell lung cancer by sex and histology: a real-world, patient-level analysis
    Tuminello, Stephanie
    Alpert, Naomi
    Veluswamy, Rajwanth R.
    Kumar, Arvind
    Gomez, Jorge E.
    Flores, Raja
    Taioli, Emanuela
    BMC CANCER, 2022, 22 (01)
  • [10] Modulation of chemoimmunotherapy efficacy in non-small cell lung cancer by sex and histology: a real-world, patient-level analysis
    Stephanie Tuminello
    Naomi Alpert
    Rajwanth R. Veluswamy
    Arvind Kumar
    Jorge E. Gomez
    Raja Flores
    Emanuela Taioli
    BMC Cancer, 22
12345